A Response to the Recommendations for Using Dexamethasone for the Treatment of COVID-19: The Dark Side of Dexamethasone

Abstract

Keywords

dexamethasone COVID-19 SARS-CoV-2 cytokines

Get full access to this article

View all access options for this article.

References

Zaim

Chong

Sankaranarayanan

, et al. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):100618–100618.

Liang

Wang

M-L

Chien

C-S

, et al. Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection. Front Immunol. 2020;11:1022.

Coperchini

Chiovato

Croce

, et al. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32.

WHO. Archived from the original on 16 June 2020. Published 2020. Accessed June 20, 2020. https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients

Ericson-Neilsen

Kaye

. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014;14(2):203–207.

Liu

Ahmet

Ward

, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30.

Black

Grodzinsky

. Dexamethasone: chondroprotective corticosteroid or catabolic killer? Eur Cell Mater. 2019;38:246–263.

Youssef

Novosad

Winthrop

. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157–x.

Ling

S-B

Lin

Y-X

, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020;133(9):1039–1043.

10.

Singh

Majumdar

Singh

, et al. Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician’s perspective. Diabetes Metab Syndr. 2020;14(5):971–978.

11.

WHO. The role of the pharmacist in the health care system. preparing the future pharmacist: curricular development. Report of the Third WHO Consultative Group on the Role of the Pharmacist, Vancouver, Canada, August 27-29, 1997. Geneva: World Health Organization; 1997. Document no WHO/PHARM/97/599. Accessed November 11, 2020. https://appswhoint/iris/handle/10665/63817